[1] Taranta A, Brama M, Teti A, et al. The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro [J]. Bone, 2002, 30(2): 368-76. [2] 唐井钢,李娟,吴贺勇.喂饲补肾中药的血清对成骨细胞的生物学作用[J].第一军医大学学报,2004,24(11):1248-50.Tang JG, Li J, Wu HY. Biological effect of serum of kidney tonifying traditional Chinese drug-fed rats on cultured osteoblasts[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2004, 24(11): 1248-50. [3] 朱文菁,金慰芳,张丽丽,等.MTT法分析培养成骨细胞的存活和增殖能力[J].上海医科大学学报,1995,22(4):254-7.Zhu WJ, Jin WF, Zhang LL, et al. Use of MTT assay for determinaition of osteoblasts viability and proliferation in vitro [J]. J Shanghai Med Univ, 1995, 22(4): 254-7. [4] 姜泊,张亚历,周殿元,等.分子生物学常用试验方法[J] 北京:人民军医出版社,1996.53. [5] Romas E, Sims NA, Hards DK, et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis[J]. Am J Pathol, 2002, 161(4): 1419-27. [6] Qu Q, Perala HM, Kapanen A, et al. Estrogen enhances differentiation of osteoblast in mouse bone marrow culture [J]. Bone, 1998, -22: 201. [7] Fiorelli G, Martineti V, Gori F, et al. Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1 [J]. Biochem Biophys Res Commun, 1997, 240(3): 573-9. [8] HsiehYF, Silva MJ. In vivo fatigue loading of the rat ulna induces both bone formation and resorption and leads to time-related changes in bone mechanical properties and density [J]. J Orthop Res, 2002, 20(4): 764-71. [9] Fujita D, Yamashita N, Iita S, et al. Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells [J]. Prostaglandins Leukot Essent Fatty Acids, 2003,68(5): 351-8. |